购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Apoptosis
    (3)
  • IGF-1R
    (3)
  • PPAR
    (3)
  • p38 MAPK
    (3)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (21)
  • 5日内发货
    (13)
  • 20日内发货
    (5)
  • 35日内发货
    (8)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "insulin-induced"的结果
筛选
搜索结果
TargetMol产品目录中 "

insulin-induced

"的结果
  • 抑制剂&激动剂
    67
    TargetMol | Inhibitors_Agonists
  • 化合物库
    1
    TargetMol | Compound_Libraries
  • 重组蛋白
    14
    TargetMol | Recombinant_Protein
  • 多肽产品
    16
    TargetMol | Peptide_Products
  • 染料试剂
    1
    TargetMol | Dye_Reagents
  • 天然产物
    12
    TargetMol | Natural_Products
  • 同位素
    3
    TargetMol | Isotope_Products
  • 分子与细胞研究
    2
    TargetMol | Inhibitors_Agonists
  • Fatostatin hydrobromide
    Fatostatin HBr
    T6832298197-04-3
    Fatostatin hydrobromide (Fatostatin A HBr) 是一种 SREBP 活化的特异性抑制剂,可抑制 SREBP-1 和 SREBP-2 的活化。它与 SCAP (SREBP 裂解激活蛋白) 结合,抑制 SREBPs 的 ER-Golgi 易位。它具有抗肿瘤作用,能抑制 ob ob 小鼠的高血糖。它抑制了细胞中成脂基因的转录。
    • ¥ 196
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • Fatostatin
    T9266125256-00-0
    Fatostatin A 是一种SREBP 活化的特异性抑制剂,能够抑制 SREBP-1 和 SREBP-2 的活化。它与 SCAP (SREBP 裂解激活蛋白) 结合,抑制 SREBPs 的 ER-Golgi 易位。它具有抗肿瘤活性,能抑制ob ob 小鼠的高血糖。它抑制细胞中成脂基因的转录。
    • ¥ 237
    In stock
    规格
    数量
  • Suramin Sodium Salt
    苏拉明钠盐, 苏拉明钠, Suramin hexasodium salt, NF-060, BAY-205
    T2160129-46-4
    Suramin Sodium Salt (BAY-205) 是可逆的竞争性蛋白酪氨酸磷酸酶抑制剂。它抑制 IP5K,是抗寄生虫,抗肿瘤和抗血管生成剂。它是sirtuins 的有效抑制剂,也是 SARS-CoV-2 RNA 依赖性 RNA 聚合酶抑制剂。
    • ¥ 279
    In stock
    规格
    数量
    TargetMol | Inhibitor Hot
  • RH01386
    T13867301177-36-6In house
    RH01386是可以预防 ER 应激诱导的β细胞功能障碍和死亡、抑制促凋亡基因表达的小分子。它恢复内质网应激受损的葡萄糖刺激的胰岛素分泌反应。对2型糖尿病具有潜在的研究价值。
    • ¥ 1070
    In stock
    规格
    数量
  • AACOCF3
    Arachidonyltrifluoromethane, Arachidonyl trifluoromethyl ketone
    T21681149301-79-1In house
    AACOCF3(Arachidonyl trifluoromethyl ketone)是一种细胞可渗透的三氟甲基酮类花生四烯酸模拟物。它是一个强效且选择性的85-kDa胞质型磷脂酶A2(cPLA2)缓慢结合抑制剂。通过阻止钙离子载体挑战的血小板中花生四烯酸和12-羟基二十四碳五烯酸的生成,AACOCF3抑制了它们的合成。此外,AACOCF3还能抑制从分离的大鼠岛细胞中诱导的葡萄糖引起的胰岛素释放。鉴于其多样的应用,AACOCF3对心血管疾病研究具有潜在的应用价值。
    • ¥ 700
    In stock
    规格
    数量
  • LI-2242
    T720342762762-17-2In house
    LI-2242是一种强效肌醇六磷酸激酶(IP6K)抑制剂,对 IP6K1、IP6K2、IP6K3和 IPMK 的 IC50s 分别为31 nM、42 nM、8.7 nM 和1944 nM。LI-2242通过减少增强脂质吸收、脂质稳定和脂肪生成的基因的表达,改善了肝脏脂肪变性,增强体外脂肪细胞和肝细胞的线粒体耗氧率(OCR)和胰岛素信号传导。 LI-2242可改善饮食诱导的小鼠肥胖症、高血糖症和肝脂肪变性。LI-2242可用于研究 II 型糖尿病、肥胖症、代谢并发症、静脉血栓和精神疾病。
    • ¥ 12800
    待询
    规格
    数量
  • Allicin
    大蒜素
    T3123539-86-6
    Allicin 具有抗氧化、杀菌、抗癌、抗炎活性,对肠上皮细胞具有抑制性免疫调节作用。 Allicin 能显着抑制胰岛素诱导的血管平滑肌细胞的增殖和迁移,这可能与抑制 ERK 信号通路的激活有关。 Allicin 有利于降低高胆固醇血症大鼠的血液胆固醇、甘油三酯水平和收缩压,它可能有益于影响动脉粥样硬化的两个危险因素——高脂血症和高血压。
    • ¥ 122
    In stock
    规格
    数量
  • Oxfenicine
    4-羟基-L-苯甘氨酸, 4-Hydroxy-L-phenylglycine
    T478532462-30-9
    Oxfenicine (4-Hydroxy-L-phenylglycine) 是具有口服活性的肉碱棕榈酰转移酶-1 抑制剂。它在缺血期间保护心脏免受坏死组织的损害。它可抑制心脏中脂肪酸的氧化。
    • ¥ 298
    In stock
    规格
    数量
  • Taurochenodeoxycholic acid sodium
    牛磺鹅去氧胆酸钠盐, Sodium taurochenodeoxycholate, 牛磺鹅去氧胆酸钠
    TN22156009-98-9
    Taurochenodeoxycholic acid sodium (Sodium taurochenodeoxycholate) 是动物胆汁酸的主要生物活性物质之一。它可诱导细胞凋亡,具有抗炎和免疫调节作用。
    • ¥ 298
    In stock
    规格
    数量
  • CLT-28643
    CLT28643
    T713681153631-91-4
    CLT-28643是一种有效和特异性的α5β1-Integrin抑制剂,能够预防青光眼滤过手术(GFS)的纤维化,抑制肿瘤生长和血管生成,在博来霉素诱导的肺纤维化模型中抑制纤维化和炎症,改善肥胖小鼠H9C2细胞的胰岛素敏感性和心脏功能。
    • ¥ 1980
    In stock
    规格
    数量
  • Galantide acetate
    Galantide acetate(138579-66-5 Free base)
    T15368L
    Galantide acetate 是一种特殊的甘丙肽受体 (galanin receptor) 拮抗剂,是一种由甘丙肽和 P 物质片段组成的肽段,在大鼠下丘脑可识别两类甘丙肽结合位点 (KD 分别小于 0.1 nM 和 ~6 nM)。Galantide 剂量依赖性 (IC50=1.0 nM) 拮抗甘丙肽介导的葡萄糖诱导的小鼠胰岛胰岛素分泌抑制。Galantide acetate 似乎与单一的 SP 受体群结合 (KD~40 nM)。
    • ¥ 1270 TargetMol
    In stock
    规格
    数量
  • D5D-IN-326
    T150431236767-85-3
    D5D-IN-326 is an orally active delta-5 desaturase (D5D) inhibitor (IC50s: 72 and 22 nM for rat and human D5D in enzymic and cell-based assays). It has no effect on D6D or D9D activity. D5D-IN-326 reduces insulin resistance and decreases body weight in die
    • ¥ 10600
    6-8周
    规格
    数量
  • PPARγ agonist 15
    T203583
    PPARγ agonist15 (Compound 7c) 是PPARγ的激动剂,能够抑制 α-淀粉酶 (HPA) 和 α-葡萄糖苷酶 (HLAG) 的表达,IC50分别为 28.35 µM 和 26.21 µM。此外,它还能在L6肌管细胞中促进葡萄糖摄取,并在大鼠Streptozotocin-诱发的糖尿病模型中改善葡萄糖稳态、胰岛素敏感性和脂质代谢。
    • 待询
    规格
    数量
  • Efaroxan hydrochloride
    盐酸盐依法克生, RX821037 hydrochloride, RX 821037 hydrochloride
    T2276089197-00-2
    Efaroxan hydrochloride(盐酸盐依法克生)是Efaroxan的盐形式。Efaroxan 是一种选择性、可口服的α2 肾上腺素受体 (α2-adrenoceptor) 拮抗剂,可提高静息血浆胰岛素水平,并显著增强肾上腺素诱导的胰岛素水平升高。
    • ¥ 248
    In stock
    规格
    数量
  • HX 531
    T22843188844-34-0
    HX 531 是RXR 拮抗剂 (IC50值为18 nM)。HX 531能降低小鼠白色脂肪组织(WAT)、骨骼肌和肝脏中的组织 TG 含量来预防 HF 饮食诱导的肥胖、胰岛素抵抗和糖尿病。
    • ¥ 381
    In stock
    规格
    数量
  • AMG-221
    AMG221
    T266171095565-81-3
    AMG-221 is a potent and selective 11β-HSD1 inhibitor. AMG-221 decreased fed blood glucose and insulin levels and reduced body weight in diet-induced obesity mice.
    • ¥ 11700
    6-8周
    规格
    数量
  • AZD-9164 bromide
    AZD9164,AZD-9164,AZD 9164
    T267241034916-72-7
    AMG-221 is a potent and selective 11β-HSD1 inhibitor. AMG 221 potently blocked 11β-HSD1 activity, producing sustained inhibition for the 24-hour study duration as measured in ex vivo adipose samples. AMG-221 decreased fed blood glucose and insulin levels
    • ¥ 10600
    6-8周
    规格
    数量
  • FK614
    FK-614, FK 614, ATx-08-001, ATx-08001
    T27324193012-35-0
    FK-614 is a selective agonist of peroxisome proliferator-activated receptor gamma. FK-614 improves peripheral glucose utilization while decreases hepatic insulin extraction in alloxan-induced diabetic dogs.
    • ¥ 10600
    6-8周
    规格
    数量
  • AZD6482 (S-isomer)
    AZD-6482,AZD 6482,AZD6482 (S),AZD6482
    T302611173900-37-2
    AZD6482 (S-isomer) is a potent, selective, ATP-competitive PI3Kβ inhibitor (IC(50) 0.01 μm), which can inhibit insulin-induced in vitro glucose uptake by human adipocytes (IC(50) is 4.4 μm).
    • ¥ 11700
    6-8周
    规格
    数量
  • Secretin (1-6)
    N-terminal hexapeptide, Secretin
    T3460021012-75-9
    Secretin (1-6) is the N-terminal part of secretin. It can produce vitro glucose-dependent insulin release induced by secretin.
    • 待询
    规格
    数量
  • FKGK 18
    T356221071001-09-6
    FKGK 18 is an inhibitor of group VIA (GVIA) calcium-independent phospholipase A2 (iPLA2). It inhibits GVIA iPLA2 by 99.9% at 0.091 mole fraction in a mixed micelle activity assay and is selective for GVIA iPLA2 over GIVA cPLA2 and GV sPLA2 where it shows 80.8 and 36.8% inhibition, respectively. FKGK 18 inhibits iPLA2β activity in cytosolic extracts from INS-1 cells overexpressing iPLA2β (IC50 = ~50 nM) as well as iPLA2γ activity in mouse heart membrane fractions (IC50s = ~1-3 μM). It inhibits glucose-induced increases in prostaglandin E2 production and insulin secretion in human pancreatic islets when used at a concentration of 10 μM and inhibits thapsigargin-induced apoptosis in INS-1 cells overexpressing iPLA2β in a concentration-dependent manner. FKGK 18 (20 mg/kg, 3 times per week) reduces blood glucose levels in an intraperitoneal glucose tolerance test, decreases the incidence of diabetes, and increases serum insulin levels in non-obese diabetic (NOD) mice.
    • 待估
    35日内发货
    规格
    数量
  • Obestatin (human) (trifluoroacetate salt)
    T35787
    Obestatin is a 23 amino acid peptide hormone with a conserved C-terminal glycine residue and amidation site that is formed by cleavage of the ghrelin and obestatin prepropeptide.1It binds to the orphan receptor GPR39 (Kd= 1 nM) and stimulates cAMP production in CHO and HEK293 cells overexpressing human GPR39. Obestatin inhibits contraction of isolated mouse jejunum muscle strips induced by ghrelin .In vivo, obestatin (12.5-1,000 nmol/kg) suppresses food intake in a time- and dose-dependent manner and reduces body weight gain and gastric emptying in mice. Obestatin (0.22 g per animal) also reduces food intake and glucose response without affecting plasma insulin responses in fasted high-fat diet fed mice.2 1.Zhang, J.V., Ren, P.C., Avsian-Kretchmer, O., et al.Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intakeScience310(5750)996-999(2005) 2.Subasinghage, A.P., Green, B.D., Flatt, P.R., et al.Metabolic and structural properties of human obestatin {1-23} and two fragment peptidesPeptides31(9)1697-1705(2010)
    • 待估
    35日内发货
    规格
    数量
  • MBX-8025 (sodium salt)
    T35799
    MBX-8025 is an agonist of peroxisome proliferator-activated receptor δ (PPARδ).1 It is greater than 750- and 2,500-fold selective for PPARδ over PPARα and PPARγ. MBX-8025 (10 mg/kg per day for eight weeks) reduces increases in fasting blood glucose and serum insulin levels, and decreases insulin resistance in Alms1 mutant (foz/foz) mice fed an atherogenic diet as a model of diet-induced obesity, type 2 diabetes, and non-alcoholic steatohepatitis (NASH).2 It also decreases serum alanine transaminase (ALT), as well as serum and hepatic cholesterol and triglyceride, levels and reduces markers of NASH in the same model. |1. Bays, H.E., Schwartz, S., Littlejohn, T., 3rd, et al. MBX-8025, a novel peroxisome proliferator receptor-δ agonist: Lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. J. Clin. Endocrinol. Metab. 96(9), 2889-2897 (2011).|2. Haczeyni, F., Wang, H., Barn, V., et al. The selective peroxisome proliferator-activated receptor-delta agonist seladelpar reverses nonalcoholic steatohepatitis pathology by abrogating lipotoxicity in diabetic obese mice. Hepatol. Commun. 1(7), 663-674 (2017).
    • 待估
    35日内发货
    规格
    数量
  • C20 Sphingomyelin (d18:1/20:0)
    T35809121999-68-6
    C20 Sphingomyelin is a naturally occurring sphingolipid. Levels of C20 sphingomyelin are upregulated in the hippocampus of rats with diabetes induced by streptozotocin and in human plasma where it is positively correlated with insulin resistance in obese humans. C20 sphingomyelin is also upregulated in the liver of a mouse model of Niemann-Pick type C1 disease, a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder. The plasma concentration of C20 sphingomyelin is decreased in men with prostate cancer.
    • 待询
    规格
    数量